Exagen Inc.

06/09/2026 | Press release | Distributed by Public on 06/09/2026 14:14

Proxy Results (Form 8-K)

Item 5.07. Submission of Matters to a Vote of Security Holders.
Exagen Inc. (the "Company") held its 2026 annual meeting of stockholders (the "Annual Meeting") on June 9, 2026. At the Annual Meeting, the Company's stockholders voted on three proposals, as described below. Each of the proposals was described in detail in the Company's definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 27, 2026 (the "Proxy Statement"). The vote totals noted below are final voting results from the Annual Meeting.
Proposal 1
The Company's stockholders elected the following two Class I directors for a three-year term of office expiring at the Company's 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until such director's earlier death, resignation or removal.
Name
Votes For
Votes Withheld
Broker Non-Votes
Tina S. Nova, Ph.D.
8,094,349 220,954 8,663,346
Scott Kahn, Ph.D.
6,295,837 2,019,466 8,663,346
Proposal 2
The Company's stockholders ratified the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Votes For
Votes Against
Abstentions
Broker Non-Votes
16,955,368 4 23,277
__
Proposal 3
The Company's stockholders approved, by an advisory vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.
Votes For
Votes Against
Abstentions
Broker Non-Votes
8,271,156 22,870 21,277 8,663,346
Exagen Inc. published this content on June 09, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 09, 2026 at 20:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]